Literature DB >> 6277259

Surgical experience with pancreatic and periampullary cancer.

F P Herter, A M Cooperman, T N Ahlborn, C Antinori.   

Abstract

Between 1940 and 1978, 179 patients underwent pancreatic resection (64 total, 102 Whipple, 13 distal) at the Presbyterian Hospital, predominantly for carcinoma of the pancreas and periampullary area. With respect to operative morbidity and mortality and survival, these patients have been compared with 141 patients subjected to pancreatic biopsy only, and with 172 by-passed for palliation. Likewise, total pancreatectomy has been compared to pancreaticoduodenectomy (Whipple) in terms of safety and efficacy. The overall major postoperative complication rate for pancreatic resection was 36%, in contrast with 13.5% for biopsy only and 16.8% for by-pass. Of the resected cases with major complications postoperatively, roughly half died, a mortality of 17.9%. Patients who underwent Whipple resections fared significantly better than did those having total pancreatectomies; the postoperative mortality following 102 Whipples was 14.7%, as compared with 23.4% for total pancreatectomies. Intra-abdominal sepsis accounted for most of the postoperative deaths; nine pancreatic and four biliary leaks or fistulae followed Whipple resections. The later complications were of interest; 18 patients undergoing biliary-en-teric by-pass procedures later developed gastroduodenal obstruction, 15 of whom required reoperation, and in 18 survivors of pancreatic resection, upper gastrointestinal hemorrhage (mostly from marginal ulcers) developed, necessitating surgery in seven. Brittle diabetes was a problem in nine patients following pancreatectomy. Survival rates were discouraging in all categories. For ductal carcinoma of the pancreas, median survival for biopsy only was two months, for by-pass six months, for total pancreatectomy nine months, and for Whipple resection 14 months. There were three five-year survivors following resection, a rate of 4.5%. Five-year survival rates following resection for ampullary, common duct, duodenal, and islet cell cancer were 27.8, 33.3, 27.3, and 37.5%, respectively. It is concluded that survival after resection for ductal pancreatic cancer is so rare as to be considered more a biologic aberration than a result of radical surgery. Despite theoretical advantages of total pancreatectomy over Whipple resections, our experience would suggest that the latter can be carried out with lower morbidity and mortality, and with equal chance for cure. Resection for pancreatic cancer should not be abandoned, but rather undertaken with greater selectivity. Operative morbidity and mortality can probably be improved additionally by preoperative transhepatic biliary decompression, and later complications reduced by including vagotomy with gastric resection at the time of pancreatectomy and by performing prophylactic gastroenterostomies in conjunction with by-pass procedures.

Entities:  

Mesh:

Year:  1982        PMID: 6277259      PMCID: PMC1352631          DOI: 10.1097/00000658-198203000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  THE RATIONALE OF RADICAL SURGERY FOR CANCER OF THE PANCREAS AND AMPULLARY REGION.

Authors:  A O Whipple
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

2.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

3.  Attempted curative resection of ductal carcinoma of the pancreas: review of Mayo Clinic experience, 1951-1975.

Authors:  A J Edis; P D Kiernan; W F Taylor
Journal:  Mayo Clin Proc       Date:  1980-09       Impact factor: 7.616

4.  Histopathology in the evaluation of total pancreatectomy for ductal carcinoma.

Authors:  A F Tryka; J R Brooks
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

5.  Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients.

Authors:  T M Shapiro
Journal:  Ann Surg       Date:  1975-12       Impact factor: 12.969

6.  Carcinoma of the pancreas and periampullary region.

Authors:  J F Forrest; W P Longmire
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

7.  Total pancreatectomy for cancer. An appraisal of 65 cases.

Authors:  I Ihse; P Lilja; B Arnesjö; S Bengmark
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

  7 in total
  45 in total

Review 1.  Pylorus-preserving pancreatoduodenectomy--technical aspects.

Authors:  J W Braasch; M Gagner
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

3.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

4.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

5.  Radical pancreatectomy for pancreatic cancer in the elderly. Is it safe and justified?

Authors:  M P Spencer; M G Sarr; D M Nagorney
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

Review 6.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

7.  Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer.

Authors:  T Nagakawa; M Kayahara; T Ohta; K Ueno; I Konishi; I Miyazaki
Journal:  Int J Pancreatol       Date:  1991-10

8.  [Prognostically relevant factors in cancer of Vater's ampulla].

Authors:  T Böttger; J Zech; W Weber; K Sorger; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1989

9.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

10.  Pancreatic anastomosis disruption seven years postpancreaticoduodenectomy.

Authors:  Walid Faraj; Zaki Abou Zahr; Deborah Mukherji; Ahmad Zaghal; Mohamed Khalife
Journal:  Case Rep Med       Date:  2010-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.